347 related articles for article (PubMed ID: 35891639)
1. Building a Network of Adverse Outcome Pathways (AOPs) Incorporating the Tau-Driven AOP Toward Memory Loss (AOP429).
Tsamou M; Roggen EL
J Alzheimers Dis Rep; 2022; 6(1):271-296. PubMed ID: 35891639
[TBL] [Abstract][Full Text] [Related]
2. A Tau-Driven Adverse Outcome Pathway Blueprint Toward Memory Loss in Sporadic (Late-Onset) Alzheimer's Disease with Plausible Molecular Initiating Event Plug-Ins for Environmental Neurotoxicants.
Tsamou M; Pistollato F; Roggen EL
J Alzheimers Dis; 2021; 81(2):459-485. PubMed ID: 33843671
[TBL] [Abstract][Full Text] [Related]
3. Development of the Adverse Outcome Pathway (AOP): Chronic binding of antagonist to N-methyl-d-aspartate receptors (NMDARs) during brain development induces impairment of learning and memory abilities of children.
Sachana M; Rolaki A; Bal-Price A
Toxicol Appl Pharmacol; 2018 Sep; 354():153-175. PubMed ID: 29524501
[TBL] [Abstract][Full Text] [Related]
4. An integrative systems biology strategy to support the development of adverse outcome pathways (AOPs): a case study on radiation-induced microcephaly.
Jaylet T; Quintens R; Armant O; Audouze K
Front Cell Dev Biol; 2023; 11():1197204. PubMed ID: 37427375
[TBL] [Abstract][Full Text] [Related]
5. Linking nanomaterial-induced mitochondrial dysfunction to existing adverse outcome pathways for chemicals.
Murugadoss S; Vinković Vrček I; Schaffert A; Paparella M; Pem B; Sosnowska A; Stępnik M; Martens M; Willighagen EL; Puzyn T; Roxana Cimpan M; Lemaire F; Mertens B; Dusinska M; Fessard V; Hoet PH
ALTEX; 2024 Jan; 41(1):76-90. PubMed ID: 37606097
[TBL] [Abstract][Full Text] [Related]
6. A strategy towards the generation of testable adverse outcome pathways for nanomaterials.
Murugadoss S; Vinković Vrček I; Pem B; Jagiello K; Judzinska B; Sosnowska A; Martens M; Willighagen EL; Puzyn T; Dusinska M; Cimpan MR; Fessard V; Hoet PH
ALTEX; 2021; 38(4):580-594. PubMed ID: 34008034
[TBL] [Abstract][Full Text] [Related]
7. Introducing WikiPathways as a Data-Source to Support Adverse Outcome Pathways for Regulatory Risk Assessment of Chemicals and Nanomaterials.
Martens M; Verbruggen T; Nymark P; Grafström R; Burgoon LD; Aladjov H; Torres Andón F; Evelo CT; Willighagen EL
Front Genet; 2018; 9():661. PubMed ID: 30622555
[TBL] [Abstract][Full Text] [Related]
8. Semantic characterization of adverse outcome pathways.
Wang RL
Aquat Toxicol; 2020 May; 222():105478. PubMed ID: 32278258
[TBL] [Abstract][Full Text] [Related]
9. Quantification of an Adverse Outcome Pathway Network by Bayesian Regression and Bayesian Network Modeling.
Moe SJ; Wolf R; Xie L; Landis WG; Kotamäki N; Tollefsen KE
Integr Environ Assess Manag; 2021 Jan; 17(1):147-164. PubMed ID: 32965776
[TBL] [Abstract][Full Text] [Related]
10. Development of a data-driven approach to Adverse Outcome Pathway network generation: a case study on the EATS-modalities.
Wiklund L; Caccia S; Pípal M; Nymark P; Beronius A
Front Toxicol; 2023; 5():1183824. PubMed ID: 37229356
[TBL] [Abstract][Full Text] [Related]
11. An integrative data-centric approach to derivation and characterization of an adverse outcome pathway network for cadmium-induced toxicity.
Sahoo AK; Chivukula N; Ramesh K; Singha J; Marigoudar SR; Sharma KV; Samal A
Sci Total Environ; 2024 Apr; 920():170968. PubMed ID: 38367714
[TBL] [Abstract][Full Text] [Related]
12. Developing adverse outcome pathways on silver nanoparticle-induced reproductive toxicity via oxidative stress in the nematode Caenorhabditis elegans using a Bayesian network model.
Jeong J; Song T; Chatterjee N; Choi I; Cha YK; Choi J
Nanotoxicology; 2018 Dec; 12(10):1182-1197. PubMed ID: 30663905
[TBL] [Abstract][Full Text] [Related]
13. Adverse outcome pathway (AOP) development I: strategies and principles.
Villeneuve DL; Crump D; Garcia-Reyero N; Hecker M; Hutchinson TH; LaLone CA; Landesmann B; Lettieri T; Munn S; Nepelska M; Ottinger MA; Vergauwen L; Whelan M
Toxicol Sci; 2014 Dec; 142(2):312-20. PubMed ID: 25466378
[TBL] [Abstract][Full Text] [Related]
14. Development of a putative adverse outcome pathway network for male rat reproductive tract abnormalities with specific considerations for the androgen sensitive window of development.
Palermo CM; Foreman JE; Wikoff DS; Lea I
Curr Res Toxicol; 2021; 2():254-271. PubMed ID: 34401750
[TBL] [Abstract][Full Text] [Related]
15. Putative adverse outcome pathways relevant to neurotoxicity.
Bal-Price A; Crofton KM; Sachana M; Shafer TJ; Behl M; Forsby A; Hargreaves A; Landesmann B; Lein PJ; Louisse J; Monnet-Tschudi F; Paini A; Rolaki A; Schrattenholz A; Suñol C; van Thriel C; Whelan M; Fritsche E
Crit Rev Toxicol; 2015 Jan; 45(1):83-91. PubMed ID: 25605028
[TBL] [Abstract][Full Text] [Related]
16. Building an adverse outcome pathway network for estrogen-, androgen- and steroidogenesis-mediated reproductive toxicity.
Zilliacus J; Draskau MK; Johansson HKL; Svingen T; Beronius A
Front Toxicol; 2024; 6():1357717. PubMed ID: 38601197
[No Abstract] [Full Text] [Related]
17. Adverse outcome pathways and linkages to transcriptomic effects relevant to ionizing radiation injury.
Yu J; Tu W; Payne A; Rudyk C; Cuadros Sanchez S; Khilji S; Kumarathasan P; Subedi S; Haley B; Wong A; Anghel C; Wang Y; Chauhan V
Int J Radiat Biol; 2022; 98(12):1789-1801. PubMed ID: 35939063
[TBL] [Abstract][Full Text] [Related]
18. Investigation of a derived adverse outcome pathway (AOP) network for endocrine-mediated perturbations.
Ravichandran J; Karthikeyan BS; Samal A
Sci Total Environ; 2022 Jun; 826():154112. PubMed ID: 35219661
[TBL] [Abstract][Full Text] [Related]
19. Development of adverse outcome pathways relevant for the identification of substances having endocrine disruption properties Uterine adenocarcinoma as adverse outcome.
; Hernandez-Jerez AF; Adriaanse P; Aldrich A; Berny P; Coja T; Duquesne S; Focks A; Millet M; Pelkonen O; Pieper S; Tiktak A; Topping CJ; Widenfalk A; Wilks M; Wolterink G; Angeli K; Recordati C; Van Durseen M; Aiassa E; Lanzoni A; Lostia A; Martino L; Guajardo IPM; Panzarea M; Terron A; Marinovich M
EFSA J; 2023 Feb; 21(2):e07744. PubMed ID: 36818642
[TBL] [Abstract][Full Text] [Related]
20. Adverse outcome pathway: a path toward better data consolidation and global co-ordination of radiation research.
Chauhan V; Beaton D; Hamada N; Wilkins R; Burtt J; Leblanc J; Cool D; Garnier-Laplace J; Laurier D; Le Y; Yamada Y; Tollefsen KE
Int J Radiat Biol; 2022; 98(12):1694-1703. PubMed ID: 34919011
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
